Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity
Authors:
Open Access
- 20 September 2022
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 34 (43) , e2203518
Abstract
Extracellular matrix (ECM) is crucial in various biological functions during tumor progression, including induction of anoikis resistance and cell adhesion‐mediated drug resistance (CAM‐DR). Fibronectin (FN) is a vital ECM component with direct regulatory effects on ECM‐mediated anoikis resistance and CAM‐DR, making it an attractive and innovative therapeutic target for depriving ECM in tumor tissue. Herein, an ECM deprivation system (EDS) is developed based on FN targeting self‐assembly peptide for constructing nanofibers in the ECM of renal cell carcinoma (RCC), which contributes to: i) targeting and recognizing FN to form nanofibers for long‐term retention in ECM, ii) reversing anoikis resistance via arresting the FN signaling pathway, and iii) serving as a drug‐loading platform for sensitizing chemotherapy by ameliorating CAM‐DR. The results reveal that EDS significantly reverses anoikis resistance of RCC cells by inhibiting the phosphorylation of FAK, a positive regulator of the FN signaling pathway. Meanwhile, EDS serves as a chemotherapy‐sensitizer of cancer, exerting significant synergistic effects with doxorubicin (DOX). In vivo validation experiments show that EDS effectively suppresses metastasis and tumor growth with chemotherapy resistance. Collectively, the innovative EDS notably inhibits the tumor‐promoting effect of ECM and may provide a novel approach for suppressing ECM and enhancing chemo‐drug sensitivity.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFB3801000)
- National Natural Science Foundation of China (82172000, U20A20385, 81971135)
This publication has 42 references indexed in Scilit:
- Every step of the way: integrins in cancer progression and metastasisNature Reviews Cancer, 2018
- Self‐Assembled Peptide‐Based Nanomaterials for Biomedical Imaging and TherapyAdvanced Materials, 2018
- In Situ shRNA Synthesis on DNA–Polylactide Nanoparticles to Treat Multidrug Resistant Breast CancerAdvanced Materials, 2018
- Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeuticsHuman Reproduction Update, 2017
- MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic ProgressionCancer Research, 2017
- SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphomaBlood, 2017
- Transformable Nanomaterials as an Artificial Extracellular Matrix for Inhibiting Tumor Invasion and MetastasisACS Nano, 2017
- Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer TheranosticsACS Nano, 2015
- Self-Assembled Tat Nanofibers as Effective Drug Carrier and TransporterACS Nano, 2013
- Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemiaLeukemia, 2007